— Know what they know.
Not Investment Advice
Also trades as: 1521.HK (HKSE) · $vol 0M

FGHQF OTC

Frontage Holdings Corporation
1W: +0.0% 1M: +16.7% 3M: +29.6% YTD: +16.8% 1Y: +16.8% 3Y: -46.4% 5Y: -78.1%
$0.17
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 60 · $354.9M mcap · 503M float · 0.011% daily turnover · Short 91% of daily vol

Cash Flow Trends

Operating Cash Flow
$41M +2.3% ▲
5Y CAGR: +15.1%
Capital Expenditures
$26M -21.5% ▼
5Y CAGR: +13.0%
Free Cash Flow
$15M -19.1% ▼
5Y CAGR: +19.5%
Dividends Paid
$0 +0.0% ▲
Buybacks
$11M -164.8% ▼
Net Change in Cash
-$9M +73.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$17M$18M$26M$11M$3M
Depreciation & Amort.$12M$24M$30M$36M$38M
Stock-Based Comp.$935K$8M$5M$3M$3M
Change in Working Capital$4M-$12M$2M-$9M-$8M
Other Non-Cash Items$19M$75M$62M-$513K$5M
Operating Cash Flow$32M$45M$62M$40M$41M
— Investing Activities —
Capital Expenditures-$15M-$50M-$48M-$21M-$26M
Acquisitions (Net)-$17M-$49M-$100M-$69M-$18M
Investment Purchases-$2M-$68M-$28M-$13M$0
Investment Sales$4M$58M$28M$14M$1M
Other Investing$0$2M$0$478K$735K
Investing Cash Flow-$30M-$107M-$149M-$88M-$41M
— Financing Activities —
Net Debt Issuance-$500K$11K$50M$23M$15M
Stock Repurchased$0$0-$8M-$4M-$11M
Dividends Paid$0$0$0$0$0
Other Financing-$6M-$8M-$10M-$6M-$21M
Financing Cash Flow-$3M-$6M$31M$13M-$10M
Net Change in Cash$4M-$67M-$58M-$34M-$9M
Cash End of Period$212M$146M$88M$53M$44M
Free Cash Flow$21M-$4M$14M$19M$15M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms